| scholarly article | Q13442814 |
| P50 | author | Blossom Damania | Q27921691 |
| Louise Giffin | Q74933010 | ||
| P2093 | author name string | John A West | |
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells | Q24293449 | ||
| Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas | Q24564315 | ||
| KSHV: pathways to tumorigenesis and persistent infection | Q27026000 | ||
| CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor | Q28199550 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice | Q28266642 | ||
| The global health burden of infection-associated cancers in the year 2002 | Q28290871 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src | Q28508235 | ||
| Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo | Q28588612 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity | Q33282964 | ||
| Perturbation of lytic and latent gammaherpesvirus infection in the absence of the inhibitory receptor CEACAM1 | Q33484744 | ||
| Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression | Q33653424 | ||
| Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. | Q33819690 | ||
| Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. | Q33939333 | ||
| Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders | Q33939338 | ||
| Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa | Q34218212 | ||
| Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. | Q34408877 | ||
| Human cytomegalovirus-encoded pUL7 is a novel CEACAM1-like molecule responsible for promotion of angiogenesis | Q34440895 | ||
| HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway | Q34542341 | ||
| Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease | Q73427381 | ||
| Serum viral interleukin-6 in AIDS-related multicentric Castleman disease | Q73768899 | ||
| CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease | Q74099040 | ||
| Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus | Q77136406 | ||
| The expression of CD66a and possible roles in colorectal adenoma and adenocarcinoma | Q79401885 | ||
| CEACAM1, a novel serum biomarker for pancreatic cancer | Q80188196 | ||
| Pro-angiogenic signaling by the endothelial presence of CEACAM1 | Q80984514 | ||
| On the role of CEACAM1 in cancer | Q81232134 | ||
| Systemic dysregulation of CEACAM1 in melanoma patients | Q84295467 | ||
| Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator | Q34782463 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation | Q35137826 | ||
| CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production | Q35138138 | ||
| CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells | Q35627666 | ||
| Human herpesvirus 8 viral interleukin-6 interacts with splice variant 2 of vitamin K epoxide reductase complex subunit 1. | Q35689626 | ||
| Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease | Q35764989 | ||
| Human herpesvirus 8 encodes a homolog of interleukin-6. | Q35876140 | ||
| HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice | Q36018434 | ||
| Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin | Q37010247 | ||
| Determinants of secretion and intracellular localization of human herpesvirus 8 interleukin-6. | Q37232908 | ||
| Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformation | Q37447587 | ||
| The expression and modulation of CEACAM1 and tumor cell transformation | Q38023157 | ||
| Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis | Q38125604 | ||
| KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways | Q38318315 | ||
| The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases | Q38477338 | ||
| Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection | Q38610318 | ||
| Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1. | Q38985652 | ||
| Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6. | Q39290036 | ||
| Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer | Q39574908 | ||
| Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus | Q39729318 | ||
| The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions | Q39877021 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. | Q40216819 | ||
| Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. | Q40479962 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism | Q40534487 | ||
| Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression | Q40537413 | ||
| Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion | Q40872607 | ||
| Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. | Q40890381 | ||
| A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit | Q41098043 | ||
| Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. | Q41125455 | ||
| Human herpesvirus 8 interleukin-6 contributes to primary effusion lymphoma cell viability via suppression of proapoptotic cathepsin D, a cointeraction partner of vitamin K epoxide reductase complex subunit 1 variant 2. | Q41909015 | ||
| Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells | Q42141115 | ||
| cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function | Q42809766 | ||
| Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. | Q42814766 | ||
| Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin | Q43763073 | ||
| High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. | Q44424254 | ||
| Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. | Q45769785 | ||
| CEACAM1: a novel urinary marker for bladder cancer detection | Q47678360 | ||
| Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions | Q47747746 | ||
| The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors | Q47755368 | ||
| To the editor: Murine gammaherpesvirus 68 (MHV-68) escapes from NK-cell-mediated immune surveillance by a CEACAM1-mediated immune evasion mechanism. | Q51841441 | ||
| CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | Q53287381 | ||
| Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. | Q53442183 | ||
| Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P921 | main subject | endothelium | Q111140 |
| cell migration | Q189092 | ||
| P304 | page(s) | e01499-15 | |
| P577 | publication date | 2015-12-08 | |
| P1433 | published in | mBio | Q15817061 |
| P1476 | title | Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration | |
| P478 | volume | 6 |
| Q26741576 | A Central Role for STAT3 in Gammaherpesvirus-Life Cycle and -Diseases |
| Q89868075 | Epstein-Barr Virus and Human Herpesvirus 8 in Idiopathic Pulmonary Fibrosis |
| Q90379391 | Human Cytomegalovirus Upregulates Expression of HCLS1 Resulting in Increased Cell Motility and Transendothelial Migration during Latency |
| Q41919772 | Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes |
| Q60949741 | Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral IL-6 (vIL-6) Enhances Immunoglobulin Class-Switch Recombination |
| Q92185487 | Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q39173806 | Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus |
| Q93211764 | Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis |
| Q91168794 | Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-κB activation, and promotion of cell invasion and angiogenesis |
| Q59126441 | The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model |
| Q94562806 | Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1 |
| Q96586662 | p300 Promotes Cell Proliferation through Suppressing Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Reactivation in the Infected B-Lymphoma Cells |
Search more.